Related Experiment Video
Updated: Jun 30, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Optimization of the formulation for a candidate lyophilised tetanus toxoid reference preparation
P Matejtschuk1, K Malik, R Tierney
1National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN63QG, United Kingdom. pmatejt@nibsc.ac.uk
A new tetanus toxoid formulation using trehalose and sodium chloride was developed. This stable formulation is now a World Health Organization International Standard for vaccine quality control.
Area of Science:
- Biotechnology
- Vaccinology
- Analytical Chemistry
Background:
- Tetanus toxoid is crucial for standardizing vaccine production assays.
- Establishing antigenic purity requires reliable reference materials.
- Existing standards may need replacement to ensure continued vaccine quality.
Purpose of the Study:
- To develop and characterize a new primary reference material for tetanus toxoid.
- To assess the stability and suitability of various formulations for lyophilization.
- To identify an optimal formulation for a World Health Organization (WHO) International Standard (IS).
Main Methods:
- Assessed multiple tetanus toxoid formulations, followed by lyophilization.
- Measured relative Lf (flocculation) content using Ramon flocculation, SRD, and ELISA assays.
- Evaluated formulation stability through accelerated degradation studies and thermal analysis.
Main Results:
- Glycine-containing formulations were unsuitable for flocculation tests.
- Sorbitol and trehalose formulations demonstrated suitability.
- The trehalose/sodium chloride formulation exhibited superior stability and performance, leading to its adoption as a WHO IS.
Conclusions:
- The trehalose/sodium chloride formulation is optimal for a tetanus toxoid reference standard.
- Lyophilization screening using thermal analysis and microscopy aids in biological reference material development.
- The new WHO IS ensures accurate standardization in tetanus toxoid vaccine production.
More Related Videos
10:16Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
Published on: March 19, 2019
05:44A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
Published on: December 9, 2022